Senate Gives Hemp THC Products A Lifeline By Including Provisions To Delay Planned Federal Ban In New Spending Bill

Key Points:

• U.S. Senate leaders have included provisions in a new spending bill to delay the federal recriminalization of hemp THC products until December 11, providing more time for advocates to push for comprehensive regulation rather than prohibition.
• The 2018 Farm Bill legalized hemp derivatives with less than 0.3% delta-9 THC, but new legislation signed last year redefined hemp to allow only products with 0.4 milligrams of total THC per container, effective November 12, prompting industry concerns over potential bans on popular full-spectrum CBD products.
• Bipartisan bills in the House, led by Reps. James Comer and Andy Barr, seek to delay the hemp THC ban and implement regulatory frameworks including age limits, testing, and labeling, with some White House support, though no congressional leadership has yet fully endorsed these proposals.
• Former President Trump and White House officials have publicly urged Congress to update hemp laws to preserve access to full-spectrum CBD, highlighting its therapeutic benefits and supporting farmers, while a new Medicare initiative aims to cover hemp-derived products for eligible seniors.
• Industry groups and lawmakers anticipate a Senate companion bill to Barr’s proposal, with bipartisan support seen as a rare opportunity for cooperation amid broader political divisions, while consumer shifts toward licensed marijuana businesses are reported due to state-level hemp bans.